Serratia infections: from military experiments to current practice

SD Mahlen - Clinical microbiology reviews, 2011 - Am Soc Microbiol
Serratia species, in particular Serratia marcescens, are significant human pathogens. S.
marcescens has a long and interesting taxonomic, medical experimentation, military …

Extended-spectrum β-lactamases: a clinical update

DL Paterson, RA Bonomo - Clinical microbiology reviews, 2005 - Am Soc Microbiol
Extended-spectrum β-lactamases (ESBLs) are a rapidly evolving group of β-lactamases
which share the ability to hydrolyze third-generation cephalosporins and aztreonam yet are …

Extended-spectrum β-lactamases in Gram Negative Bacteria

D Rawat, D Nair - Journal of global infectious diseases, 2010 - journals.lww.com
Extended-spectrum β-lactamases (ESBLs) are a group of plasmid-mediated, diverse,
complex and rapidly evolving enzymes that are posing a major therapeutic challenge today …

Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

PA Bradford - Clinical microbiology reviews, 2001 - Am Soc Microbiol
SUMMARY β-Lactamases continue to be the leading cause of resistance to β-lactam
antibiotics among gram-negative bacteria. In recent years there has been an increased …

Growing group of extended-spectrum β-lactamases: the CTX-M enzymes

R Bonnet - Antimicrobial agents and chemotherapy, 2004 - Am Soc Microbiol
The production of-lactamases is the predominant cause of resistance to-lactam antibiotics in
gram-negative bacteria. These enzymes cleave the amide bond in the-lactam ring …

The new β-lactamases

GA Jacoby, LS Munoz-Price - New England Journal of Medicine, 2005 - Mass Medical Soc
The β-lactamases are the major bacterial defense of gram-negative bacteria against β-
lactam antibiotics. This review details the many types of β-lactamases, explains how they …

Prevalence and spread of extended‐spectrum β‐lactamase‐producing Enterobacteriaceae in Europe

R Cantón, A Novais, A Valverde… - Clinical Microbiology …, 2008 - Wiley Online Library
Extended‐spectrum β‐lactamases (ESBLs) represent a major threat among resistant
bacterial isolates. The first types described were derivatives of the TEM‐1, TEM‐2 and SHV …

Resistance to β-lactam antibiotics

K Poole - Cellular and Molecular Life Sciences CMLS, 2004 - Springer
Abstract β-lactams have a long history in the treatment of infectious diseases, though their
use has been and continues to be confounded by the development of resistance in target …

Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals

M Saladin, VTB Cao, T Lambert… - FEMS microbiology …, 2002 - academic.oup.com
Nine clinical isolates of Enterobacteriaceae (six Escherichia coli and three Proteus mirabilis)
isolated in three Parisian hospitals between 1989 and 2000 showed a particular extended …

[HTML][HTML] Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms

M Gniadkowski - Clinical Microbiology and Infection, 2001 - Elsevier
The rapid and irrepressible increase in antimicrobial resistance of pathogenic bacteria that
has been observed over the last two decades is widely accepted to be one of the major …